Thiomorpholine → HCID 57496144, compound

HRID 1797950Notes

Reaction equation

HRID 1797950 reaction equation
[C:1]([C:3]1[CH:4]=[C:5]([NH:9][C:10](=[O:33])[NH:11][C:12]2[CH:17]=[CH:16][C:15]([S:18]([NH:21][CH2:22][C:23]3[CH:28]=[CH:27][C:26]([S:29](=[O:32])(=[O:31])[NH2:30])=[CH:25][CH:24]=3)(=[O:20])=[O:19])=[CH:14][CH:13]=2)[CH:6]=[CH:7][CH:8]=1)#[N:2].[NH:34]1[CH2:39][CH2:38][S:37][CH2:36][CH2:35]1>>[NH:2]=[C:1]([N:34]1[CH2:39][CH2:38][S:37][CH2:36][CH2:35]1)[C:3]1[CH:4]=[C:5]([NH:9][C:10](=[O:33])[NH:11][C:12]2[CH:17]=[CH:16][C:15]([S:18]([NH:21][CH2:22][C:23]3[CH:28]=[CH:27][C:26]([S:29](=[O:32])(=[O:31])[NH2:30])=[CH:25][CH:24]=3)(=[O:20])=[O:19])=[CH:14][CH:13]=2)[CH:6]=[CH:7][CH:8]=1

Participants

3

Procedure

The title compound was prepared from 4-(3-(3-cyanophenyl)ureido)-N-(4-sulfamoylbenzyl)benzenesulfonamide following procedure C and using 1.1 equivalents of thiomorpholine as secondary amine. The product was purified by preparative TLC (eluent DCM/MeOH 8:2).

Workup

  1. customThe product was purified by preparative TLC (eluent DCM/MeOH 8:2)

Sources & evidence

ORD record
ord-37ff793aa8414b0db1fc2ee20fb92a6f
Source dataset
uspto-grants-2013_01
Patent number
US08343963B2

Reaction notes

Loading…